Production of marked prolongation of islet xenograft survival (rat to mouse) by local release of mouse and rat antilymphocyte sera at transplant site.

Aebischer, P; Lacy, P E; Gerasimidi-Vazeou, A; Hauptfeld, V

Aebischer, P; Lacy, P E; Gerasimidi-Vazeou, A; Hauptfeld, V.

Affiliation

Aebischer P; Artificial Organ Laboratory, Brown University, Providence, Rhode Island.

Diabetes ; 40(4): 482-5, 1991 Apr.

Article in En | MEDLINE | ID: mdl-2010049

Subject(s)

Antilymphocyte Serum/administration & dosage; Diabetes Mellitus, Experimental/surgery; Graft Survival; Islets of Langerhans Transplantation/immunology; Transplantation, Heterologous; Animals; Antilymphocyte Serum/therapeutic use; Blood Glucose/metabolism; Diabetes Mellitus, Experimental/blood; Drug Implants; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred WF; Species Specificity

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Transplantation, Heterologous / Islets of Langerhans Transplantation / Diabetes Mellitus, Experimental / Graft Survival / Antilymphocyte Serum Limits: Animals Language: En Journal: Diabetes Year: 1991 Document type: Article

Search on Google

XML

PubMed Links